Skip to main content
. Author manuscript; available in PMC: 2022 May 10.
Published in final edited form as: J Clin Oncol. 2008 Aug 1;26(22):3709–3714. doi: 10.1200/JCO.2007.10.8332

Table 1.

Dose Levels

Dose Level No. of Patients Sorafenib (mg bid) Bevacizumab (mg/kg q 2 weeks) Range of Cycles
1 Cohort 1: 6
Cohort 2: 27		 200 5 1–22+
2 6 200 10 3–6
3 0 400 10 (did not accrue)

Abbreviations: bid, twice per day; q, every.